< Back to search
Filter
1

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

for
Liver Cancer, Rhabdomyosarcoma, Malignant Rhabdoid Tumor,
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 1 - 21

Code: NCT04715191

Phase 1, Recruiting

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor

for
Neoplasms, Tenosynovial Giant Cell Tumor
Location: Beverly Hills CA
Sponsor: Abbisko Therapeutics Co, Ltd

Sex: All

Age: 18+

Code: NCT04192344

Phase 1, Recruiting

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

for
Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung,
Location: Boston MA, Montreal, Baltimore MD, Ottawa, Toronto,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT06131840

Phase 1, Recruiting

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Boston MA, Pittsburgh PA, Houston TX, Newport Beach CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT05372640

Phase 1, Recruiting

Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

for
Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor, Neuroblastoma,
Location: Valhalla NY
Sponsor: New York Medical College

Sex: All

Age: 1 - 30

Code: NCT04308330

Phase 1, Recruiting

Interested in new solid tumors trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

for
Muscle-Invasive Bladder Carcinoma,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06529822

Phase 1, Recruiting

Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer

for
Colorectal Neoplasms, Gastric Neoplasms, Cholangiocarcinoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2+

Code: NCT01915225

Recruiting

The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors

for
Non-Small-Cell Lung Carcinoma, Malignant Melanoma,
Location: Elizabethtown KY
Sponsor: VastBiome

Sex: All

Age: 18+

Code: NCT05037825

Recruiting

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

for
Gastrointestinal Stromal Tumors, Small-cell Lung Cancer,
Location: Cleveland OH, Ann Arbor MI, Houston TX, Portland OR
Sponsor: Novelty Nobility, Inc.

Sex: All

Age: 18+

Code: NCT06805825

Phase 1, Recruiting

A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

for
Malignant Neoplasm
Location: Fairfax VA, Houston TX, San Antonio TX
Sponsor: Tyligand Pharmaceuticals (Suzhou) Limited

Sex: All

Age: 18 - 70+

Code: NCT06385925

Phase 1, Phase 2, Recruiting

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

for
Castrate Resistant Prostate Cancer, NUT Carcinoma,
Location: Boston MA, Jacksonville FL, Rochester MN, Houston TX,
Sponsor: Epigenetix, Inc.

Sex: All

Age: 18+

Code: NCT05488548

Phase 1, Recruiting

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

for
Neoplasms, Neoplasm Metastasis, Non-Small-Cell Lung Cancer
Location: Boston MA, Canton OH, Detroit MI
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.

Sex: All

Age: 18+

Code: NCT03797391

Phase 1, Phase 2, Recruiting

First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies

for
Triple Negative Breast Cancer, Hormone-Resistant Breast Cancer,
Location: Baltimore MD
Sponsor: A&G Pharmaceutical Inc.

Sex: All

Age: 18+

Code: NCT05627960

Phase 1, Recruiting

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

for
Large Cell Neuroendocrine Carcinoma,
Location: Princeton NJ, Glen Burnie MD, Tampa FL, Cleveland OH,
Sponsor: Molecular Partners AG

Sex: All

Age: 18+

Code: NCT07278479

Phase 1, Phase 2, Recruiting

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

for
Advanced Breast Carcinoma, Advanced Endometrial Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05092373

Phase 1, Recruiting

A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors

for
ER+ HER2- Advanced Breast Cancer,
Location: Providence RI, Nashville TN, St Louis MO, Houston TX
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT06188520

Phase 1, Phase 2, Recruiting

A Study of DM002 in Patients With Advanced Solid Tumors

for
Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms,
Location: Huntersville NC, Houston TX, Oklahoma City OK,
Sponsor: Xadcera Biopharmaceutical (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06751329

Phase 1, Phase 2, Recruiting

Study of SIR2501 in Solid Tumor Patients Receiving Paclitaxel

for
Chemotherapy-induced Peripheral Neuropathy
Location: East Brunswick NJ, Baltimore MD, Hollywood FL
Sponsor: Sironax USA, Inc.

Sex: All

Age: 18+

Code: NCT07765446

Phase 2, Recruiting

BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion

for
Metastatic Biliary Tract Carcinoma, Metastatic Colon Carcinoma,
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07594626

Phase 1, Phase 2, Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

for
Melanoma (Skin Cancer),
Location: Lake Success NY, Fairfax VA, Detroit MI, Cincinnati OH,
Sponsor: Aminex Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07287917

Phase 1, Phase 2, Recruiting